Globe Life Inc. (GL)
NYSE: GL · Real-Time Price · USD
140.47
-0.58 (-0.41%)
Jul 31, 2025, 4:00 PM - Market closed
Orchard Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 4,771 | 4,666 | 4,456 | 4,310 | 4,095 | 3,814 | Upgrade |
Total Interest & Dividend Income | 1,130 | 1,136 | 1,057 | 991.8 | 956.69 | 927.06 | Upgrade |
Gain (Loss) on Sale of Investments | -18.29 | -24.19 | -65.68 | -76.55 | 59.32 | -4.37 | Upgrade |
Other Revenue | 0.32 | 0.35 | 0.31 | 1.25 | 1.22 | 1.33 | Upgrade |
| 5,883 | 5,778 | 5,448 | 5,227 | 5,112 | 4,738 | Upgrade | |
Revenue Growth (YoY) | 4.02% | 6.07% | 4.22% | 2.24% | 7.90% | 4.65% | Upgrade |
Policy Benefits | 2,934 | 2,894 | 2,864 | 2,825 | 2,659 | 2,573 | Upgrade |
Policy Acquisition & Underwriting Costs | 1,034 | 995.05 | 919.67 | 845.45 | 762.87 | 880.61 | Upgrade |
Selling, General & Administrative | 15.7 | 15.7 | 19.2 | 9.4 | 10 | 9.8 | Upgrade |
Other Operating Expenses | 382.17 | 357.45 | 316.2 | 315.81 | 283.62 | 252.07 | Upgrade |
Total Operating Expenses | 4,406 | 4,303 | 4,150 | 4,032 | 3,746 | 3,751 | Upgrade |
Operating Income | 1,477 | 1,475 | 1,297 | 1,195 | 1,366 | 986.66 | Upgrade |
Interest Expense | -136.94 | -127.09 | -102.32 | -90.4 | -83.49 | -86.7 | Upgrade |
EBT Excluding Unusual Items | 1,340 | 1,348 | 1,195 | 1,105 | 1,283 | 899.96 | Upgrade |
Legal Settlements | -21.58 | -21.58 | -0.9 | -2.5 | -8.14 | -3.28 | Upgrade |
Pretax Income | 1,319 | 1,327 | 1,194 | 1,102 | 1,275 | 896.68 | Upgrade |
Income Tax Expense | 253.27 | 255.88 | 223.51 | 207.73 | 243.5 | 164.91 | Upgrade |
Earnings From Continuing Ops. | 1,066 | 1,071 | 970.76 | 894.39 | 1,031 | 731.77 | Upgrade |
Net Income | 1,066 | 1,071 | 970.76 | 894.39 | 1,031 | 731.77 | Upgrade |
Net Income to Common | 1,066 | 1,071 | 970.76 | 894.39 | 1,031 | 731.77 | Upgrade |
Net Income Growth | 2.02% | 10.30% | 8.54% | -13.26% | 40.91% | -3.81% | Upgrade |
Shares Outstanding (Basic) | 84 | 89 | 95 | 98 | 102 | 106 | Upgrade |
Shares Outstanding (Diluted) | 85 | 90 | 96 | 99 | 103 | 107 | Upgrade |
Shares Change (YoY) | -9.94% | -6.96% | -2.65% | -4.06% | -3.78% | -3.73% | Upgrade |
EPS (Basic) | 12.64 | 11.99 | 10.21 | 9.13 | 10.10 | 6.90 | Upgrade |
EPS (Diluted) | 12.54 | 11.94 | 10.07 | 9.04 | 9.99 | 6.82 | Upgrade |
EPS Growth | 13.31% | 18.57% | 11.39% | -9.51% | 46.48% | -0.13% | Upgrade |
Free Cash Flow | - | 1,331 | 1,433 | 1,394 | 1,399 | 1,435 | Upgrade |
Free Cash Flow Per Share | - | 14.85 | 14.87 | 14.09 | 13.56 | 13.38 | Upgrade |
Dividend Per Share | 1.020 | 0.960 | 0.900 | 0.830 | 0.790 | 0.750 | Upgrade |
Dividend Growth | 9.68% | 6.67% | 8.43% | 5.06% | 5.33% | 8.70% | Upgrade |
Operating Margin | 25.11% | 25.53% | 23.82% | 22.86% | 26.73% | 20.82% | Upgrade |
Profit Margin | 18.11% | 18.53% | 17.82% | 17.11% | 20.17% | 15.45% | Upgrade |
Free Cash Flow Margin | - | 23.04% | 26.30% | 26.68% | 27.38% | 30.28% | Upgrade |
EBITDA | 1,507 | 1,502 | 1,318 | 1,216 | 1,386 | 1,004 | Upgrade |
EBITDA Margin | 25.62% | 26.00% | 24.20% | 23.27% | 27.12% | 21.18% | Upgrade |
D&A For EBITDA | 30 | 27 | 21 | 21 | 20 | 17 | Upgrade |
EBIT | 1,477 | 1,475 | 1,297 | 1,195 | 1,366 | 986.66 | Upgrade |
EBIT Margin | 25.11% | 25.53% | 23.82% | 22.86% | 26.73% | 20.82% | Upgrade |
Effective Tax Rate | 19.20% | 19.29% | 18.71% | 18.85% | 19.10% | 18.39% | Upgrade |
Revenue as Reported | 5,883 | 5,778 | 5,448 | 5,227 | 5,112 | 4,738 | Upgrade |
Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.